Table 2

Baseline characteristics of the overall population and propensity score matching population according to stent techniques

VariablesOverall populationsPropensity matched population
Complex stenting (n=196)Simple stenting (n=360)p ValueComplex stenting (n=139)Simple stenting (n=139)p Value
Age, years (±SD)65±9.964±11.10.71864±10.164±10.90.833
Sex (male, %)146 (74.5)262 (72.8)0.663107 (77.0)102 (73.4)0.488
Diabetes mellitus (%)53 (27.0)130 (36.1)0.03042 (30.2)42 (30.2)0.999
Hypertension (%)119 (60.7)209 (58.1)0.54379 (56.8)79 (56.8)0.999
Hyperlipidaemia (%)55 (28.1)121 (33.6)0.17944 (31.7)62 (44.6)0.056
Smoking (%)42 (21.4)93 (25.8)0.24730 (21.6)38 (27.3)0.264
Previous PCI (%)39 (19.9)66 (18.3)0.65329 (20.9)30 (21.6)0.883
Previous MI (%)17 (8.7)30 (8.3)0.89012 (8.6)13 (9.4)0.834
Previous heart failure (%)5 (2.6)5 (1.4)0.3341 (0.7)3 (2.2)0.622
Cerebrovascular disease (%)23 (11.7)34 (9.4)0.39517 (12.2)10 (7.2)0.156
Peripheral vascular disease (%)3 (1.5)7 (1.9)0.9993 (2.2)3 (2.2)0.999
Chronic renal failure (%)10 (5.1)12 (3.3)0.3637 (5.0)3 (2.2)0.198
Clinical manifestation0.0810.538
 Stable angina (%)70 (35.7)156 (43.3)51 (36.7)56 (40.3)
 Acute coronary syndrome (%)126 (64.3)204 (56.7)88 (63.3)83 (59.7)
Extent of diseased vessel<0.00010.961
 Left main only (%)16 (8.2)54 (15.0)15 (10.8)15 (10.8)
 Left main plus 1 vessel disease (%)26 (13.2)133 (36.9)15 (10.8)15 (10.8)
 Left main plus 2 vessel diseases (%)74 (37.8)90 (25.0)57 (41.0)61 (43.9)
 Left main plus 3 vessel diseases (%)80 (40.8)83 (23.1)52 (37.4)48 (34.5)
RCA involvement (%)97 (49.5)157 (43.6)0.18466 (47.5)81 (58.3)0.072
Restenotic lesion5 (2.6)15 (4.2)0.3285 (3.6)5 (3.6)0.999
Left ventricular ejection fraction (±SD)61.35±10.6960.25±11.070.29861.46±9.8760.62±9.970.518
EUROscore4.0±2.73.8±2.40.4733.8±2.73.8±2.40.962
SYNTAX score26.6±10.124.7±10.20.04527.6±10.327.6±11.10.982
  • CABG, coronary artery bypass grafting; MI, myocardial infarction; PCI, percutaneous coronary intervention; RCA, right coronary artery; SYNTAX, synergy between percutaneous coronary intervention with taxus and cardiac surgery.